These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6219022)

  • 1. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice.
    Yamada K; Nonaka K; Hanafusa T; Miyazaki A; Toyoshima H; Tarui S
    Diabetes; 1982 Sep; 31(9):749-53. PubMed ID: 6219022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of nicotinamide in the onset and course of streptozotocin-induced diabetes].
    Shishko PI; Sadykova RE; Shmagov AIu; Ragovin KE; Abugova IA; Shamkhalova MSh
    Probl Endokrinol (Mosk); 1993; 39(3):38-40. PubMed ID: 8058679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined casein-free-nicotinamide diet prevents diabetes in the NOD mouse with minimum insulitis.
    Reddy S; Bibby NJ; Wu D; Swinney C; Barrow G; Elliott RB
    Diabetes Res Clin Pract; 1995 Aug; 29(2):83-92. PubMed ID: 8591703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels.
    Reddy S; Bibby NJ; Elliott RB
    Diabetes Res; 1990 Oct; 15(2):95-102. PubMed ID: 2151892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.
    Atkinson MA; Maclaren NK; Luchetta R
    Diabetes; 1990 Aug; 39(8):933-7. PubMed ID: 2197139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
    Heineke EW; Johnson MB; Dillberger JE; Robinson KM
    Diabetes; 1993 Dec; 42(12):1721-30. PubMed ID: 8243818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes.
    Reich EP; Scaringe D; Yagi J; Sherwin RS; Janeway CA
    Diabetes; 1989 Dec; 38(12):1647-51. PubMed ID: 2684716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age.
    Kim JY; Chi JK; Kim EJ; Park SY; Kim YW; Lee SK
    J Korean Med Sci; 1997 Aug; 12(4):293-7. PubMed ID: 9288627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
    Zhang C; Gui L; Xu Y; Wu T; Liu D
    Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liposome and complete Freund's adjuvant for the prevention of insulitis in non-obese diabetic mice].
    Su H; Jiang TJ; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):32-4. PubMed ID: 12575229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.